ProPhase Labs GAAP EPS of $0.03 beats by $0.13, revenue of $19.3M beats by $4.17M
- ProPhase Labs press release (NASDAQ:PRPH): Q1 GAAP EPS of $0.03 beats by $0.13.
- Revenue of $19.3M (-59.4% Y/Y) beats by $4.17M.
- As revenue mix transitions, Company still achieves positive net income and significant adjusted EBITDA while acquiring and developing biotech, genomics and diagnostic assets with multi-billion-dollar potential
- Company highlights key strategic initiatives to grow underlying value in 2023 and beyond.
- Shares +5.52% PM.